Candidemia in the critically ill patient

International Journal of Antimicrobial Agents

Volumn 32, Issue SUPPL. 2, 2008, Pages

  Picazo, Juan J ^a   González Romo, Fernando ^a   Candel, F Javier ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Candidemia; Critically ill; Diagnosis; Epidemiology; Therapy

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CASPOFUNGIN; CORTICOSTEROID; FLUCONAZOLE; FUNGAL DNA; FUNGUS ANTIBODY; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ARTICLE; CANDIDA; CANDIDEMIA; CLINICAL FEATURE; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; FUNGAL DETECTION; FUNGAL STRAIN; HOST RESISTANCE; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STRAIN DIFFERENCE; SURVIVAL RATE;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; CRITICAL ILLNESS; FUNGEMIA; HUMANS; INTENSIVE CARE UNITS;

EID: 55649106770     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(08)70005-0     Document Type: Article

References (14)

1. Alonso-Valle H., Acha O., García-Palomo J.D., Fariñas-Alvarez C., Fernández-Mazarrasa C., and Fariñas M.C. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 22 (2003) 254-257
2. Pontón J., and del Palacio A. Advances and limitations in the early diagnosis of invasive yeast infections [in Spanish]. Rev Iberoam Micol 24 (2007) 181-186
3. Almirante B., Rodríguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., et al. Barcelona Candidemia Project Study Group. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43 (2005) 1829-1835
4. Pfaller M.A., Diekema D.J., Gibbs D.L., Newell V.A., Meis J.F., Gould I.M., et al., Global Antifungal Surveillance Study. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 45 (2007) 1735-1745
5. Sobel J.D. The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia. Curr Infect Dis Rep 8 (2006) 427-433
6. Forrest G.N., Weekes E., and Johnson J.K. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect 56 (2008) 126-129
7. Jordà-Marcos R., Alvarez-Lerma F., Jurado M., Palomar M., Nolla-Salas J., León M.A., et al., EPCAN Study Group. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 50 (2007) 302-310
8. Dimopoulos G., Ntziora F., Rachiotis G., Armaganidis A., and Falagas M.E. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 106 (2008) 523-529
9. Klevay M.J., Ernst E.J., Hollanbaugh J.L., Miller J.G., Pfaller M.A., and Diekema D.J. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagn Microbiol Infect Dis 60 (2008) 273-277
10. León C., Ruiz-Santana S., Saavedra P., Almirante B., Nolla-Salas J., Alvarez-Lerma F., et al., EPCAN Study Group. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34 (2006) 730-737
11. Ostrosky-Zeichner L., Sable C., Sobel J., Alexander B.D., Donowitz G., Kan V., et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26 (2007) 271-276
12. Petrikkos G., and Skiada A. Recent advances in antifungal chemotherapy. Int J Antimicrob Agents 30 (2007) 108-117
13. McMullan R., Metwally L., Coyle P.V., Hedderwick S., McCloskey B., O'Neill H.J., et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 46 (2008) 890-896
14. Reboli A.C., Rotstein C., Pappas P.G., Chapman S.W., Kett D.H., Kumar D., et al. Anidulafungin Study Group. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356 (2007) 2472-2482